<?xml version="1.0" encoding="UTF-8"?>
<ref id="B12-pharmaceutics-09-00048">
 <label>12.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Müller</surname>
    <given-names>R.H.</given-names>
   </name>
   <name>
    <surname>Mäder</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Gohla</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Solid lipid nanoparticles (SLN) for controlled drug delivery—A review of the state of the art</article-title>
  <source>Eur. J. Pharm. Biopharm.</source>
  <year>2000</year>
  <volume>50</volume>
  <fpage>161</fpage>
  <lpage>177</lpage>
  <pub-id pub-id-type="doi">10.1016/S0939-6411(00)00087-4</pub-id>
  <pub-id pub-id-type="pmid">10840199</pub-id>
 </element-citation>
</ref>
